Patent Assignment
Reel/Frame 045622/0474
Assignment of Assignor's Interest
Recorded: 2018-04-24
Pages: 6
Assignors
BEARSS, DAVID J.
Executed: 2017-09-15
SIDDIQUI-JAIN, ADAM
Executed: 2017-09-15
WHATCOTT, CLIFFORD J.
Executed: 2017-09-14
WARNER, STEVEN L.
Executed: 2017-09-15
Assignee
TOLERO PHARMACEUTICALS, INC.
2975 WEST EXECUTIVE PARKWAY, SUITE 320, LEHI, UTAH, 84043
Covered Property
(1)
Compositions and Methods for Treating Bcl-2 Inhibitor Insensitive Subjects Using Mcl-1 Inhibitors
Application:
62/557,635 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053181/0114 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053181/0133 →
Change of Name
Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059810/0102 →